Cargando…
Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells
Nearly 70% of breast cancer patients with advanced disease will develop bone metastases. Once established in bone, tumor cells produce factors that cause changes in normal bone remodeling, such as parathyroid hormone-related protein (PTHrP). While enhanced expression of PTHrP is known to stimulate o...
Autores principales: | Ruppender, Nazanin S., Merkel, Alyssa R., Martin, T. John, Mundy, Gregory R., Sterling, Julie A., Guelcher, Scott A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981576/ https://www.ncbi.nlm.nih.gov/pubmed/21085597 http://dx.doi.org/10.1371/journal.pone.0015451 |
Ejemplares similares
-
Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growth
por: Page, Jonathan M., et al.
Publicado: (2015) -
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
por: Choi, Bongkun, et al.
Publicado: (2014) -
T Cells Induce Pre-Metastatic Osteolytic Disease and Help Bone
Metastases Establishment in a Mouse Model of Metastatic Breast
Cancer
por: Monteiro, Ana Carolina, et al.
Publicado: (2013) -
Templated Three-Dimensional Engineered Bone Matrix as a Model for Breast Cancer Osteolytic Bone Metastasis Process
por: Sun, Manman, et al.
Publicado: (2021) -
Multiple Osteolytic Lesions
por: Vinayachandran, Divya, et al.
Publicado: (2013)